{
    "Trade/Device Name(s)": [
        "TRU FLU"
    ],
    "Submitter Information": "Meridian Bioscience, Inc.",
    "510(k) Number": "K071657",
    "Predicate Device Reference 510(k) Number(s)": [
        "K041626",
        "K062109"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "November 2, 2007",
    "Summary Letter Received Date": "November 2, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza Virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasal wash",
        "Nasopharyngeal aspirate",
        "Nasal swab",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral-flow immunochromatographic assay",
        "Colloidal gold immunoassay"
    ],
    "Methodologies": [
        "Immunochromatographic testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for TRU FLU rapid lateral-flow immunochromatographic assay for detection of influenza A and B viral antigens",
    "Indications for Use Summary": "Rapid, qualitative detection of influenza A and B viral nucleoprotein antigens in human nasal wash, nasopharyngeal aspirate, and nasal and nasopharyngeal swab samples from symptomatic patients; not intended for influenza C detection.",
    "fda_folder": "Microbiology"
}